ZEPP Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Zepp Health Corp (ZEPP) is not a strong buy at this moment for a beginner, long-term investor with $50,000-$100,000 available for investment. The company's financial performance shows significant revenue growth, but the sharp decline in net income, EPS, and gross margin raises concerns about profitability. Technical indicators and options data suggest a neutral to slightly bearish sentiment, and there are no recent positive news catalysts or trading signals to support an immediate buy decision.
The MACD is positive but contracting, indicating weakening momentum. RSI is neutral at 45.486, suggesting no clear overbought or oversold conditions. Moving averages are converging, showing no strong trend. The current price of $21.3 is near the S1 support level of $21.513, with the next support at $20.179. Resistance levels are at $23.672 and $25.83.
Revenue increased by 78.49% YoY in Q3 2025, indicating strong top-line growth.
Net income dropped by 87.80% YoY, EPS fell by 80.00%, and gross margin declined by 6.03% YoY, signaling profitability challenges. No recent news or trading trends from insiders or hedge funds. No recent congress trading data.
In Q3 2025, revenue increased to $75.79 million (up 78.49% YoY), but net income dropped to -$1.62 million (down 87.80% YoY). EPS decreased to -$0.01 (down 80.00% YoY), and gross margin fell to 38.16% (down 6.03% YoY).
No data available for analyst ratings or price target changes.
